The glutamate synapse as a therapeutical target: Perspectives for the future

Progress in Brain Research

Volumn 116, Issue , 1998, Pages 441-458

  Meldrum, B S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 (2H TETRAZOL 5 YLMETHYL) 2 PIPERIDINECARBOXYLIC ACID; 4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ACAMPROSATE; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; AMPA RECEPTOR AGONIST; AMPA RECEPTOR ANTAGONIST; APTIGANEL; CYCLOSERINE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEXANABINOL; DEXTROMETHORPHAN; DIZOCILPINE; ELIPRODIL; GLUTAMIC ACID; GLYCINE; KETAMINE; LAMOTRIGINE; MILACEMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; OMEGA CONOTOXIN MVIIA; PHENCYCLIDINE; REMACEMIDE; RILUZOLE; SIPATRIGINE; UNINDEXED DRUG;

ALCOHOLISM; AMNESIA; BRAIN INJURY; CLINICAL TRIAL; DRUG TARGETING; EPILEPSY; EPILEPTOGENESIS; HUMAN; HYPERALGESIA; MENTAL DISEASE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SCHIZOPHRENIA; SYNAPSE;

EID: 0031763774     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)60454-9     Document Type: Review

References (127)

1. E.W. Anthony M.E. Nevins Anxiolytic-like effects of N -methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test Eur. J. Pharmacol. 250 1993 317 324
2. A. Arai M. Kessler G. Rogers G. Lynch Effects of a memory-enhancing drug on DL-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus J. Pharmacol. Exp. Ther. 278 1996 627 638
3. J.L. Arriza W.A. Fairman J.I. Wadiche G.H. Murdoch M.P. Kavanaugh S.G. Amara Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex J. Neuroscl. 14 1994 5559 5569
4. J.L. Arriza S. Eliasof M.P. Kavanaugh S.G. Amara Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance Proc. Natl. Acad. Sci., USA 94 1997 4155 4160
5. P. Avenet J. Leonardon F. Besnard D. Graham H. Depoortere B. Scatton Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes Neuroscl. Lett. 223 1997 133 136
6. B.M. Baron B.L. Harrison J.H. Kehne C.J. Schmidt P.L.M. Van Giersbergen H.S. White B.W. Siegel Y. Senyah T.C. McCloskey G.M. Fadayel V.L. Taylor M.K. Murawsky P. Nyce F.G. Salituro Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist Eur. J. Pharmacol. 323 1997 181 192
7. M.G. Baxter T.H. Lanthorn K.M. Frick S. Golski R.-Q. Wan D.S. Olton D-cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats Neurobiol. Aging 15 1994 207 213
8. Bettler B. C. Mulle Review: Neurotransmitter receptors II. AMPA and kainate receptors Neuropharmacology 34 1995 123 139
9. F. Bordi C. Pietra L. Ziviani A. Reggiani The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat Exp. Neurol. 145 1997 425 433
10. C.R. Breese R. Freedman S.S. Leonard Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers Brain Res. 674 1995 82 90
11. A.I.M. Breukel F.H. Lopes da Silva Ghijsen W.E.J.M Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings Neurosci. Lett. 234 1997 67 70
12. A.M. Buchan Xue D.Z. Huang K.H. Smith H. Lesiuk Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia Neuroreport 2 1991 473 476
13. P.E. Castillo R.C. Malenka R.A. Nicoll Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons Nature 388 1997 182 186
14. F.A. Chaudhry K.P. Lehre M. Van Lookeren Campagne O.P. Ottersen N.C. Danbolt J. Storm-Mathisen Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry Neuron 15 1995 711 720
15. I.P. Chessell A.W. Procter P.T. Francis D.M. Bowen D-Cycloserine, a putative cognitive enhancer, facilitates activation of the N -methyl-D-aspartate receptor-ionophore complex in Alzheimer brain Brain Res. 565 1991 345 348
16. S.H. Chung M.S. Johnson Studies on soundinduced epilepsy in mice Proc. R. Soc. Lond. [Biol.] 221 1984 145 168
17. R. Chittajallu M. Vignes K.K. Dev J.M. Barnes G.L. Collingridge J.M. Henley Regulation of glutamate release by presynaptic kainate receptors in the hippocampus Nature 379 1996 78 81
18. F. Conti A. Minelli Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase J. Histochem. Cytochem. 42 1994 717 726
19. M.J. Croucher J.F. Collins B.S. Meldrum Anticonvulsant action of excitatory amino acid antagonists Science 216 1982 899 901
20. S.N. Davies D. Lodge Evidence for involvement of N -methyl-aspartate receptors in “wind-up” of class 2 neurones in the dorsal horn of the rat Brain Res. 424 1987 402 406
21. J.F.W. Deakin P. Slater M.D.C. Simpson A.C. Gilchrist W.J. Skan M.C. Royston G.P. Reynolds A.J. Cross Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia J. Neurochem. 52 1989 1781 1786
22. A.H. Dickenson A.F. Sullivan Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation Neuropharmacology 26 1987 1235 1238
23. S.L. Eastwood P.W.J. Burnet Harrison P.J GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: A reverse transcriptase-polymerase chain reaction (RTPCR) study Mol. Brain Res. 44 1997 92 98
24. S.L. Eastwood R.W. Kerwin P.J. Harrison Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non- N -methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia Biol. Psychiatry 41 1997 636 643
25. S.L. Eastwood B. McDonald P.W.J. Brunette J.P. Beckwith R.W. Kerwin P.J. Harrison Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia Mol. Brain Res. 29 1995 211 223
26. C.L. Faingold D.K. Naritoku C.A. Copley M.E. Randall A. Riaz Boersma C.A. Anderson S.P. Arneric Glutamate in the inferior colliculus plays a critical role in audiogenic seizure initiation Epilepsy Res. 13 1992 95 105
27. W.A. Fairman R.J. Vandenberg J.L. Arriza M.P. Kavanaugh S.G. Amara An excitatory amino-acid transporter with properties of a ligand-gated chloride channel Nature 375 1995 599 603
28. S. Felsby J. Nielsen L. Arendt-Nielsen T.S. Jensen NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride Pain 64 1996 283 291
29. B.B. Fredholm Adenosine and neuroprotection Green A.R. Cross A.J. Neuroprotective agents 1997 Academic Press San Diego 259 280
30. J.R.P. Geiger T. Melcher D.-S. Koh B. Sakmann P.H. Seeburg P. Jonas H. Monyer Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS Neuron 15 1995 193 204
31. R. Gill The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia Cerebrovasc. Brain Metab. Rev. 6 1994 225 256
32. R. Gill D. Lodge The neuroprotective effects of the decahydroisoquinoline, LY 215490; A novel AMPA antagonist in focal ischaemia Neuropharmacology 33 1994 1529 1536
33. R. Gill L. Nordholm D. Lodge The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model Brain Res. 580 1992 35 43
34. Q.-Z. Gong T.M. Delahunty R.J. Hamm B.G. Lyeth Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats Brain Res. 700 1995 299 302
35. J.B.P. Gramsbergen P.S. Hodgkins A. Rassoulpour W.A. Turski P. Guidetti R. Schwarcz Brain-specific modulation of kynurenic acid synthesis in the rat J. Neurochem. 69 1997 290 298
36. D.C. Goff L. Wine Glutamate in schizophrenia: Clinical and research implications Schiz. Res. 27 1997 157 168
37. R. Granger S. Deadwyler M. Davis B. Moskovitz M. Kessler G. Rogers G. Lynch Facilitation of glutamate receptors reverses an age-associated memory impairment in rats Synapse 22 1996 332 337
38. U. Heresco-Levy D.C. Javitt M. Ermilov Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia Br. J. Psychiatry 169 1996 610 617
39. M. Hollmann J. Boulter C. Maron L. Beasley J. Sullivan G. Pecht S. Heinemann Zinc potentiates agonistinduced currents at certain splice variants of the NMDA receptor Neuron 10 1993 943 954
40. M. Hollmann S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108
41. M. Ishimaru A. Kurumaji M. Toru Glutamate receptors and schizophrenia Trends Neurosci. 19 1996 416 417
42. Javitt D.C S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
43. D.C. Javitt L. Zylberman S.R. Zukin Amelioration of negative symptoms of schizophrenia by glycine Am. J. Psychiatry 151 1994 1234 1236
44. R. Kälviäinen T. Halonen A. Pitkänen P.J. Riekkinen Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: Effect of vigabatrin and carbamazepine monotherapies J. Neurochem. 60 1993 1244 1250
45. B.U. Keller Blaschke M. R. Rivosecchi M. Hollmann S.F. Heinemann A. Konnerth Identification of a subunit-specific antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels Proc. Natl. Acad. Sci. USA 90 1993 605 609
46. Kerwin S., Patel B., Meldrum C., Czudeck G.P., Reynolds 1988 Asymmetrical loss of a glutamate receptor subtype in left hippocampus in schizophrenia. Lancet (i): 583–584.
47. R. Kerwin S. Patel B. Meldrum Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem Neuroxcience 39 1990 25 32
48. K. Kieburtz A. Feigin M. McDermott P. Como D. Abwender C. Zimmerman C. Hickey Orme C. K. Claude J. Sotack J.T. Greenamyre C. Dunn I. Shoulson A controlled trial of remacemide hydrochloride in Huntington's disease Mov. Disord. 11 1996 273 277
49. G. Köhr I. Mody Kindling increases N -methyl-D-aspartate potency at single N -methyl-D-aspartate channels in dentate gyrus granule cells Neuroscience 62 1994 975 981
50. B.D. Kretschmer U. Kratzer K. Breithecker M. Koch ACEA 1021. a glycine site antagonist with minor psychotomimetic and amnestic effects in rats Eur. J. Pharmacol. 331 1997 109 116
51. J.D. Kristensen R. Karlsten T. Gordh O. Berg The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-l-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat Pain 56 1992 59 67
52. J.D. Kristensen B. Svensson T. Gordh Jr. The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans Pain 51 1992 249 253
53. J.D. Kristensen Intrathecal administration of a competitive NMDA receptor antagonist for pain treatment P.L. Herrling Excitatory amino acids: Clinical results with antagonists 1997 Academic Press San Diego 23 30
54. L. Lacomblez G. Bensimon P.N. Leigh P. Guillet V. Meininger Dose-ranging study of riluzole in amyotrophic lateral sclerosis Lancet 347 1996 1425 1431
55. J. Larson T. Lieu V. Petchpradub B. LeDuc H. Ngo G.A. Rogers G. Lynch Facilitation of olfactory learning by a modulator of AMPA receptors J. Neurosci. 15 1995 8023 8030
56. D.J. Laurie P.H. Seeburg Ligand affinities at recombinant N -methyl-D-aspartate receptors depend on subunit composition Eur. J. Pharmacol. Mol. Pharmacol. 268 1994 335 345
57. E. Leiderman I. Zylberman S.R. Zukin T.B. Cooper D.C. Javitt Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: An open-label trial Biol. Psychiatry 39 1996 213 215
58. J.P. Lhuintre M. Daoust N. Moore P. Chretien C. Saligaut G. Tran F. Boismare B. Hillemand Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics Lancet 1 1985 1014 1016
59. J.P. Lhuintre N. Moore G. Tran L. Steru S. Lancrenon M. Daoust P. Parot P. Ladure C. Zarnitsky F. Boismare B. Hillemand A double-blind randomized multicenter study of calcium acetylhomotaurine in the prevention of alcoholic relapse Alcoh. Alcoholism 25 1990 613 622
60. H. Li A.M. Buchan Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury J. Cereb. Blood Flow Metab. 13 1993 933 939
61. W. Ling-Gang P. Saggau Presynaptic inhibition of elicited neurotransmitter release TINS 20 1997 204 212
62. Lu X.-C.M. A. Williams P. Britton F.C. Tortella J. Estrada P.F. Jackson B.S. Slusher Time course of neuroprotection with NAALADase inhibition following MCAO in rats Soc. Neurosci. Abst. 23 1997 2302
63. E.D. Luby B.D. Cohen Rosenbaum G J.S. Gottlieb R. Kelley Study of a new schizophrenomimetic drug-serenyl Arch. Neurol. Psychiat. 81 1959 363 369
64. R. Lujn J.Z. Nusser D.B. Roberts R. Shigemoto P. Somogyi Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus Eur. J. Neurosci. 8 1996 1488 1500
65. G. Lynch R. Granger Ambros-Ingerson J C.M. Davis M. Kessler R. Schehr Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans Exp. Neurol. 145 1997 89 92
66. S.G. Madamba P. Schweitzer W. Zieglgänsberger G.R. Siggins Acamprosate (calcium acetylhomota-urinate) enhances the N -methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro Alcohol. Clin. Exp. Res. 20 1996 651 658
67. N. Matsuoka T.G. Aigner D-cycloserine, a partial agonist at the glycine site coupled to N -methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys J. Pharmacol. Exp. Ther. 278 1996 891 897
68. A. Maurset L.A. Skoglund O. Justveit I. Oye Comparison of ketamine and pethidine in experimental and postoperative pain Pain 36 1989 37 41
69. T.K. McIntosh D.H. Smith E. Garde Therapeutic approaches for the prevention of secondary brain injury Europ. J. Anaesthes 13 1996 291 309
70. L. Medina G. Figueredo-Cardenas J.D. Rothstein A. Reiner Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups Exp. Neurol. 142 1996 287 295
71. B.S. Meldrum Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission Cerebrovasc. Brain Metab. Rev. 2 1990 27 57
72. Meldrum B.S. Neuroprotection by NMDA and non-NMDA glutamate antagonists M.G. Palfreyman I.J. Reynolds P. Skolnick Direct and allosteric control of glutamate receptors 1994 CRC Press Boca Raton 127 138
73. S. Miller C. Romano C.W. Cotman Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes J. Neurosci. 15 1995 6103 6109
74. Monyer H. N. Burnashev D.J. Laurie B. Sakmann P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
75. R.A. Morrisett A.H. Rezvani D. Overstreet D.S. Janowsky W.A. Wilson H.S. Swartzwelder MK-801 potently inhibits alcohol withdrawal seizures in rats Eur. J. Pharmacol. 176 1990 103 105
76. A. Mukhin L. Fan A.I. Faden Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury J. Neurosci. 16 1996 6012 6020
77. T. Myhrer R.E. Paulsen Memory impairment in rats with glutamatergic temporal systems disrupted is attenuated by D-cycloserine: Effects of postoperative time of injection Psychobiology 23 1995 233 239
78. S. Nakanishi Molecular diversity of glutamate receptors and implications for brain function Science 258 1992 597 603
79. H. Ohishi C. Akazawa R. Shigemoto S. Nakanishi N. Mizuno Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain J. Comp. Neurol. 360 1995 555 570
80. M. Ohno S. Watanabe D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats Eur. J. Pharmacol. 318 1996 267 271
81. R.S. Petralia Y.X. Wang A.S. Niedzielski R.J. Wenthold The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976
82. J. Qian W.F. Colmers Saggau Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry J. Neurosci. 17 1997 8169 8177
83. D. Quartermain J. Mower M.F. Rafferty R.L. Herting T.H. Lanthorn Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention Eur. J. Pharmacol. 257 1994 7 12
84. J.M. Rho S.D. Donevan M.A. Rogawski Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate J. Pharmacol. Exp. Ther. 280 1997 1383 1391
85. J.D. Rothstein L. Jin M. Dykes-Hoberg R.W. Kuncl Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity Proc. Natl. Acad. Sci., USA 90 1993 6591 6595
86. J.D. Rothstein M. Dykes-Hoberg C.A. Pardo L.A. Bristol L. Jin R.W. Kuncl Y. Kanai M.A. Hediger Y.F. Wang J.P. Schielke D.F. Welty Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate Neuron 16 1996 675 686
87. J.D. Rothstein R.W. Kuncl Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity J. Neurochem. 65 1995 643 651
88. J.D. Rothstein L. Martin A.I. Levey M. Dykes-Hoberg L. Jin D. Wu Nash N. R.W. Kuncl Localization of neuronal and glial glutamate transporters Neuron 13 1994 713 725
89. J.D. Rothstein M. Van Kammen A.I. Levey L.J. Martin R.W. Kuncl Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann. Neurol. 38 1995 73 84
90. K.A. Rudolphi P. Schubert F.E. Parkinson B.B. Fredholm Adenosine and brain ischemia Cerebrovasc. Brain Metab. Rev. 4 1992 346 369
91. P.H. Seeburg The TINS/TiPS lecture: The molecular biology of mammalian glutamate receptor channels TINS 16 1993 359 365
92. R. Shigemoto A. Kinoshita E. Wada S. Nomura H. Ohishi M. Takada P.J. Flor A. Neki T. Abe S. Nakanishi N. Mizuno Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus J. Neurosci. 17 1997 7503 7522
93. R. Shigemoto A. Kulik J.D.B. Roberts H. Ohishi Z. Nusser T. Kaneko P. Somogyi Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone Nature 381 1996 523 525
94. T.J. Shors R.J. Servatius R.F. Thompson G. Rogers G. Lynch Enhanced glutamatergic neurotransmission facilitates classical conditioning in the freely moving rat Neurosci. Lett. 186 1995 153 156
95. J. Simeon M. Fink T. Itil D-cycloserine therapy of psychosis by symptom provocation Compr. Psychiatry 11 1970 80 88
96. R.P. Simon J.H. Swan T. Griffiths B.S. Meldrum Blockade of N -methyl-D-aspartate receptors may protect against ischaemic damage in the brain Science 226 1984 850 852
97. S.E. Smith B.S. Meldrum Cerebroprotective effect of a non- N -methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat Stroke 23 1992 861 864
98. S.E. Smith B.S. Meldrum Cerebroprotective effect of a non- N -methyl-D-aspartate antagonist, NBQX, after focal ischemia in the rat Func. Neurol. 8 1993 43 48
99. C. Speciale M. Cini H.Q. Wu P. Salvati R. Schwarcz A. Molinari M. Calabresi M. Varasi Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents Adv. Exp. Med. Biol. 398 1996 221 227
100. U. Staubli G. Rogers G. Lynch Facilitation of glutamate receptors enhances memory Proc. Natl. Acad. Sci. USA 91 1994 777 781
101. A. Stefani F. Spadoni G. Bernardi Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: Implications for neuroprotective strategies Exp. Neurol. 147 1997 115 122
102. D.N. Stephens B.S. Meldrum R. Weidmann C. Schneider M. Grutzner Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90 1986 166 169
103. S. Subramaniam J.M. Rho L. Penix S.D. Donevan R.P. Fielding M.A. Rogawski Felbamate block of the N -methyl-D-aspartate receptor J. Pharmacol. Exp. Ther. 273 1995 878 886
104. S. Sveinbjornsdottir J.W.A.S. Sander D. Upton P.J. Thompson P.N. Patsalos D. Hirt M. Emre D. Lowe J.S. Duncan The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy Epilepsy Res. 16 1993 165 174
105. R.A. Swanson J. Liu J.W. Miller J.D. Rothstein K. Farrell B.A. Stein M.C. Longuemare Neuronal regulation of glutamate transporter subtype expression in astrocytes J. Neurosci. 17 1997 932 940
106. S. Takaoka R.D. Bart R. Pearlstein A. Brinkhous D.S. Warner Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled J. Cereb. Blood Flow Metab. 17 1997 161 167
107. S. Takizawa K. Matsushima H. Fujita K. Nanri S. Ogawa Y. Shinohara A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia J. Cereb. Blood Flow Metab. 15 1995 611 618
108. K. Tanaka K. Watase T. Manabe K. Yamada M. Watanabe K. Takahashi H. Iwama T. Nishikawa N. Ichihara Hori S.M. Takimoto K. Wada Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 Science 276 1997 1699 1702
109. C.P. Taylor B.S. Meldrum Na+ channels as targets for neuroprotective drugs TIPS 16 1995 309 316
110. M.D. Temple R.J. Hamm Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury Brain Res. 741 1996 246 251
111. A.G. Thomas J.J. Vornov P.F. Jackson B.S. Slusher Inhibition of NAALADase activity is neuroprotective in cell culture model of ischemia Soc. Neurosci. Abst. 23 1997 2302
112. R. Torp F. Hoover N.C. Danbolt J. Storm-Mathisen O.P. Ottersen Differential distribution of the glutamate transporters GLT1 and rEAA1 in rat cerebral cortex and thalamus: An in situ hybridization analysis Anat. Embryol. 195 1997 317 326
113. G. Tsai L.A. Passani B.S. Slusher R. Carter L. Baer J.E. Kleinman J.T. Coyle Abnormal excitatory neurotransmitter metabolism in schizophrenic brains Arch. Gen. Psychiatry 52 1995 829 836
114. K. Valentino R. Newcomb T. Gadbois T. Singh S. Bower-sox S. Bitner A. Justice D. Yamashiro B.B. Hoffman R. Ciaranello G. Miljanich J. Ramachandran A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia Proc. Natl. Acad. Sci. USA 90 1993 7894 7897
115. T.A. Verdoorn T.H. Johansen J. Drejer E.O. Nielsen Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist Eur. J. Pharmacol. Mol. Pharmacol. 269 1994 43 49
116. M. Vignes G.L. Collingridge The synaptic activation of kainate receptors Nature 388 1997 179 182
117. A.W. Wamil H. Cheung E.W. Harris M.J. McLean Remacemide HC1 and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture Epilepsy Res. 23 1996 1 14
118. S.J. Wang C.C. Huang K.S. Hsu J.J. Tsai P.W. Gean Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones Neuroreport 7 1996 3037 3040
119. R.A. Waniewski D.L. Martin Repeated administration of γ-vinylGABA reduces rat brain glutamine synthetase activity J. Neurochem. 65 1995 355 362
120. H.S. White S.D. Brown J.H. Woodhead G.A. Skeen H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Res. 28 1997 167 179
121. J.L. Wiley A.F. Cristello R.L. Balster Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice Eur. J. Pharmacol. 294 1995 101 107
122. L.A. Wong M.L. Mayer Differential modulation by cyclothiazide and concanavalin A of desensitiation at native AMPA- and kainate-preferring glutamate receptors Molec. Pharmac. 44 1993 504 510
123. J.T. Wroblewski W.D. Blaker J.L. Meek Ornithine as a precursor of neurotransmitter glutamate: Effect of canaline on ornithine aminotransferase activity and glutamate content in the septum of rat brain Brain Res. 329 1985 161 168
124. Z. Xie Commissaris R.L. Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801 Pharmacol. Biochem. Behav. 43 1992 471 477
125. M.L. Zeise S. Kasparow M. Capogna W. Zieglgasberger Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors Eur. J. Pharmacol. 231 1993 47 52
126. N. Zerangue J.L. Arriza S.G. Amara M.P. Kavanaugh Differential modulation of human glutamate transporter subtypes by arachidonic acid J. Biol. Chem. 270 1995 6433 6435
127. N. Zerangue M.P. Kavanaugh Flux coupling in a neuronal glutamate transporter Nature 383 1996 634 637